Phase II Trial PD-L1/PD-1 Blockade Avelumab (MSB0010718C) With Chemoradiotherapy for Locally Advanced Resectablet3b-4/N1-2 Rectal Cancer (Averec Trial)

Project: Other

StatusActive
Effective start/end date12/02/1911/02/24